347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of 22 months of follow-up

• Urban Emmenegger,
• Howard Gurney,
• Emanuela Romano,
• Neal Shore,
• Margitta Retz,
• Christian Poehlein,
• Charles Schloss,
• Leonard Appleman,
• Gwenaelle Gravis,
• Loïc Mourey,
• Josep Piulats,
• Evan Yu,
• Johann De Bono,
• William Berry,
• Peter Fong,
• Cristiano Ferrario,
• Tilman Todenhoefer,
• Henry Conter,
• Brigitte Laguerre,
• Xin Tong Li

Affiliations

Urban Emmenegger

17 Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Howard Gurney

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Emanuela Romano

Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, Île-de-France, France

Neal Shore

Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA

Margitta Retz

Aff3 Dept. of UrologyUniversity Hospital, Technical University Munich Germany

Christian Poehlein

Aff400 grid.417993.10000000122600793Merck & Co., Inc. Kenilworth NJ USA

Charles Schloss

6Merck and Co., Inc., Kenilworth, NJ, USA

Leonard Appleman

UPMC, Pittsburgh, Pennsylvania, USA

Gwenaelle Gravis

Aff2 0000 0004 0598 4440grid.418443.eInstitut Paoli-Calmettes, Department of Medical Oncology 13009 Marseille France

Loïc Mourey

Aff3 grid.488470.7Service d’Oncologie médicale, Institut Universitaire du Cancer Toulouse Oncopole Toulouse France

Josep Piulats

5Catalan Cancer Institute, Barcelona, Spain

Evan Yu

Department of Complex Genetics and Epidemiology, Maastricht University, Maastricht, The Netherlands

Johann De Bono

3The ICR and Royal Marsden, London, UK

William Berry

4 Ariadne Labs, Boston, Massachusetts, USA

Peter Fong

Department of Surgery/Anesthesiology, University of South Carolina School of Medicine, Columbia, South Carolina 29203

Cristiano Ferrario

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST-IRCCS), Meldola, Italy

Tilman Todenhoefer

2Studienpraxis Urologie, Nürtingen, Germany

Henry Conter

6University of Western Ontario, brampton, Canada

Brigitte Laguerre

7Center Eugéne Marquis, Rennes, France

Xin Tong Li

16Merck and Co., Inc., Kenilworth, NJ, USA